Sign In
Buy INVZ
Innoviz Technologies Earnings Calls
| Release date | May 14, 2026 |
| EPS estimate | -$0.0600 |
| EPS actual | -$0.100 |
| EPS Surprise | -66.67% |
| Revenue estimate | 13.5M |
| Revenue actual | 7.133M |
| Revenue Surprise | -47.16% |
| Release date | Feb 25, 2026 |
| EPS estimate | -$0.0700 |
| EPS actual | -$0.0700 |
| Revenue estimate | 15M |
| Revenue actual | 12.674M |
| Revenue Surprise | -15.51% |
| Release date | Nov 12, 2025 |
| EPS estimate | -$0.0700 |
| EPS actual | -$0.0700 |
| Revenue estimate | 15M |
| Revenue actual | 15.278M |
| Revenue Surprise | 1.85% |
| Release date | Aug 13, 2025 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0900 |
| EPS Surprise | -12.50% |
| Revenue estimate | 12.75M |
| Revenue actual | 9.747M |
| Revenue Surprise | -23.55% |
Last 4 Quarters for Innoviz Technologies
Below you can see how INVZ performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 13, 2025 |
| Price on release | $1.58 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0900 |
| EPS surprise | -12.50% |
| Date | Price |
|---|---|
| Aug 07, 2025 | $1.63 |
| Aug 08, 2025 | $1.67 |
| Aug 11, 2025 | $1.70 |
| Aug 12, 2025 | $1.82 |
| Aug 13, 2025 | $1.58 |
| Aug 14, 2025 | $1.50 |
| Aug 15, 2025 | $1.78 |
| Aug 18, 2025 | $1.79 |
| Aug 19, 2025 | $1.63 |
| 4 days before | -3.07% |
| 4 days after | 3.16% |
| On release day | -5.06% |
| Change in period | 0% |
| Release date | Nov 12, 2025 |
| Price on release | $1.53 |
| EPS estimate | -$0.0700 |
| EPS actual | -$0.0700 |
| Date | Price |
|---|---|
| Nov 06, 2025 | $1.66 |
| Nov 07, 2025 | $1.67 |
| Nov 10, 2025 | $1.67 |
| Nov 11, 2025 | $1.61 |
| Nov 12, 2025 | $1.53 |
| Nov 13, 2025 | $1.38 |
| Nov 14, 2025 | $1.34 |
| Nov 17, 2025 | $1.33 |
| Nov 18, 2025 | $1.31 |
| 4 days before | -7.83% |
| 4 days after | -14.38% |
| On release day | -9.80% |
| Change in period | -21.08% |
| Release date | Feb 25, 2026 |
| Price on release | $0.89 |
| EPS estimate | -$0.0700 |
| EPS actual | -$0.0700 |
| Date | Price |
|---|---|
| Feb 19, 2026 | $0.95 |
| Feb 20, 2026 | $0.94 |
| Feb 23, 2026 | $0.92 |
| Feb 24, 2026 | $0.91 |
| Feb 25, 2026 | $0.89 |
| Feb 26, 2026 | $0.91 |
| Feb 27, 2026 | $0.85 |
| Mar 02, 2026 | $0.91 |
| Mar 03, 2026 | $0.85 |
| 4 days before | -6.32% |
| 4 days after | -4.18% |
| On release day | 1.99% |
| Change in period | -10.23% |
| Release date | May 14, 2026 |
| Price on release | $0.747 |
| EPS estimate | -$0.0600 |
| EPS actual | -$0.100 |
| EPS surprise | -66.67% |
| Date | Price |
|---|---|
| May 08, 2026 | $0.732 |
| May 11, 2026 | $0.80 |
| May 12, 2026 | $0.786 |
| May 13, 2026 | $0.92 |
| May 14, 2026 | $0.747 |
| May 15, 2026 | $0.736 |
| May 18, 2026 | $0.722 |
| May 19, 2026 | $0.700 |
| May 20, 2026 | $0.710 |
| 4 days before | 2.08% |
| 4 days after | -4.91% |
| On release day | -1.43% |
| Change in period | -2.94% |
Innoviz Technologies Earnings Call Transcript Summary of Q1 2026
Innoviz reported Q1 2026 revenue of $7.1M, noting some NRE milestone revenue shifted into later quarters but with purchase orders in place and management reiterating full-year 2026 revenue guidance of $67–$73M (≈27% YoY growth). The company shipped a record number of units in Q1 and expects shipments to accelerate in H2 as Fabrinet ramp continues. Innoviz launched the InnovizTwo Ultra-Long Range (ULR) LiDAR (up to 1 km range) and expanded into defense and homeland security (high-margin market) with early traction and partnerships (e.g., Kela and a large holding group). Automotive programs progress toward SOPs with customers including Volkswagen, Mobileye, Daimler Truck/Torc, and LOXO (LOI); Innoviz3 (with optional color) targets behind-the-windshield automotive integration. Financially, cash on hand was ~$60.1M, no long-term debt; Q1 gross margin was negative (~-22%) due to revenue mix and fixed-cost under-absorption, but management expects margin uplift as volumes ramp and NREs remain a stable dollar component while product revenue grows. Management expects 2–3 new programs in 2026 and up to $20–$30M of new NRE bookings in addition to existing plans.
